MACROGENICS, INC. (MGNX) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin -212.12%.
- 2025-12-31: Pre-Tax Margin -36.22%.
- 2025-09-30: Pre-Tax Margin 23.09%.
- 2025-06-30: Pre-Tax Margin -620.35%.
Complete source-backed pre-tax margin history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | -212.12% |
| 2025-12-31 | -36.22% |
| 2025-09-30 | 23.09% |
| 2025-06-30 | -620.35% |
| 2024-12-31 | -74.80% |
| 2024-09-30 | 50.86% |
| 2024-06-30 | -515.55% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -50.36% |
| 2024-12-31 | -44.03% |
| 2023-12-31 | -15.42% |
| 2022-12-31 | -78.82% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |